Track Cumberland Pharmaceuticals Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cumberland Pharmaceuticals Inc. CPIX Open Cumberland Pharmaceuticals Inc. in new tab

5.28 USD
EPS
-0.49
P/B
3.55
ROE
-29.81
Beta
-0.06
Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc.

🧾 Earnings Recap – Q3 2025

Cumberland Pharmaceuticals reported solid financial performance in Q3 2025, marked by strategic commercial partnerships and a focus on expanding its product portfolio. The company's revenue growth and continued operational advancements reinforce optimistic future projections.

  • Entered a joint commercialization agreement with RedHill Biopharma for Talicia, now a first-line therapy for H. pylori infections; projected 2024 net sales of $8 million.
  • Third quarter revenues reached $8.3 million, with a 12% increase year-to-date despite shipment delays.
  • Positive cash flow from operations of nearly $5 million year-to-date, indicating robust financial health amid ongoing investments.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 4, 2026
EPS-0.49
Book Value1.44
Price to Book3.55
Debt/Equity47.27
% Insiders41.600%
Growth
Revenue Growth-0.22%
Estimates
Forward P/E36.57
Forward EPS0.14

DCF Valuation

Tweak assumptions to recompute fair value for Cumberland Pharmaceuticals Inc. (CPIX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Cumberland Pharmaceuticals Inc. Logo Cumberland Pharmaceuticals Inc. Analysis (CPIX)

United States Health Care Official Website Stock

Is Cumberland Pharmaceuticals Inc. a good investment? Cumberland Pharmaceuticals Inc. (CPIX) is currently trading at 5.28 USD.

Earnings Schedule: Cumberland Pharmaceuticals Inc. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 0.14.

Investor FAQ

Does Cumberland Pharmaceuticals Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cumberland Pharmaceuticals Inc.?

Cumberland Pharmaceuticals Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -0.49.

Company Profile

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Exchange Ticker
NMS (United States) CPIX

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion